Compared with standard CAR-T cells, anti-CAIX CAR-T cells secreting anti-PD-L1 antibodies significantly increase antitumor activity, as evidenced by enhanced cytokine production and immune cell recruitment and the significant reduction in tumor size in the humanized ccRCC mouse model (200). The gene discussed is CD274; the disease is neoplasm.